Serum vitamin D concentration, viral load, and COVID-19 symptoms in outpatients

Autores/as

  • Vanessa Brito Lira de Carvalho Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0002-9255-4961
  • Margarete Almeida Freitas de Azevedo Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0003-0261-1481
  • Maisa Guimarães Silva Primo Federal University of Piauí, Teresina (PI), Brazil
  • Liriane Andressa Alves da Silva Federal University of Piauí, Teresina (PI), Brazil https://orcid.org/0000-0002-0697-8128
  • José Couras da Silva Filho Federal University of Piauí, University Hospital, Teresina (PI), Brazil
  • Adelino Soares Lima Neto Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil https://orcid.org/0000-0002-9370-0203
  • José Miguel Luz Parente Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil https://orcid.org/0000-0003-4563-2784
  • Maria do Carmo de Carvalho Martins Federal University of Piauí, Department of Biophysics and Physiology, Teresina (PI), Brazil https://orcid.org/0000-0002-9107-2485

DOI:

https://doi.org/10.11606/issn.2176-7262.rmrp.2026.230013

Palabras clave:

COVID-19, Viral load, Vitamin D

Resumen

Objective: To evaluate the relationship between serum vitamin D concentration, viral load, and COVID-19 symptoms in outpatients. Methods: This cross-sectional study included 105 adult outpatients with COVID-19 in Teresina, Brazil. Serum 25-hydroxyvitamin D concentrations were measured  by electrochemiluminescence, and viral load was estimated using RT-qPCR cycle threshold (Ct) values. Sociodemographic and clinical data were collected through structured interviews. Associations were analyzed using the Wilcoxon and Kruskal-Wallis tests. Results: The median serum vitamin D concentration ranged from 27.0 to 33.4 ng/mL. There were no significant differences in vitamin D levels by age, sex, income, education, or comorbidities. However, individuals without a partner had lower vitamin D levels (30.2 ng/mL) than those with a partner (33.4 ng/mL, p = 0.020). Participants with cough (p = 0.014) and with body aches (p = 0.029) had higher vitamin D levels. No association was  found between vitamin D concentration and viral load (p = 0.917). Conclusion: Although no association was observed between serum vitamin D and viral load, higher vitamin D concentrations were associated with the presence of cough and body aches. These findings suggest a possible immunomodulatory
role of vitamin D in COVID-19 and highlight the need for further research on its role in the immune response to SARS-CoV-2.

Descargas

Los datos de descarga aún no están disponibles.

Biografía del autor/a

  • Vanessa Brito Lira de Carvalho, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Margarete Almeida Freitas de Azevedo, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Maisa Guimarães Silva Primo, Federal University of Piauí, Teresina (PI), Brazil

    PhD student 

  • Liriane Andressa Alves da Silva, Federal University of Piauí, Teresina (PI), Brazil

    MSc 

  • José Couras da Silva Filho, Federal University of Piauí, University Hospital, Teresina (PI), Brazil

    PhD 

  • Adelino Soares Lima Neto, Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil

    PhD 

  • José Miguel Luz Parente, Federal University of Piauí, Health Sciences Center, Teresina (PI), Brazil

    PhD 

  • Maria do Carmo de Carvalho Martins, Federal University of Piauí, Department of Biophysics and Physiology, Teresina (PI), Brazil

    Post-Doctorate 

Referencias

1. Lu CC, Chen MY, Chang YL. Potential therapeutic agents against COVID-19: What we know so far. J Chin Med Assoc. 2020;83(6):534-536. Available at: https:// doi: 10.1097/JCMA.0000000000000318

2. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of hospitalized adult patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-1062. Available at: https:// doi: 10.1016/S0140-6736(20)30566-3

3. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of pneumonia caused by the new coronavirus. N Engl J Med 2020;382(13):1199-1207. Available at: https://doi: 10.1056/NEJMoa2001316

4. Wang W, Tang J, Wei F. Updated understanding of the 2019 novel coronavirus (2019 - nCoV) outbreak in Wuhan, China. J Med Virol. 2020;92(4):441-447.

Available at: https://doi.org/10.1002/jmv.25689

5. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: a systematic review. J Med Virol. 2020;92(5):479-490. Available at: https://doi.org/10.1002/jmv.25689

6. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML, et al. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 2010;5(6):e 11088.

Available at: https://doi.org/10.1371/journal.pone.0011088

7. Pinzon RT, Angela Pradana , AW. Vitamin D deficiency among patients with COVID-19: case series and recent literature review. Trop Med Health. 2020;48(1): 102. Available at : https://doi.org/10.1186/s41182-020-00277-w

8. Charoenngam N, Holick MF. Immunological effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097. Available at: https://doi.org/10.3390/nu12072097

9. Bilezikian JP, Bikle D, Hewison M, Lazaretti -Castro M, Formenti AM, Gupta A, et al. Mechanisms in endocrinology: Vitamin D and COVID-19. Eur J Endocrinol. 2020; 183(5):R133-R147. Available at: https://doi.org/10.1530/EJE-20-0665

10. Meltzer DO, Best TJ, Zhang H, Vokes T, Arora V, Solway J , et al. Association between vitamin D deficiency and treatment and incidence of COVID-19. medRxiv . 2020. Available at : https://doi: 10.1101/2020.05.08.20095893.

11. Malaguarnera L. Vitamin D3 as a potential adjuvant in the treatment of COVID-19. Nutrients. 2020;12(11):3512. Available at: https://doi.org/10.3390/nu12113512

12. Aranha C, Patel V, Bhor V, Gogoi D. Cycle threshold values in RT-PCR to determine SARS-CoV-2 viral load dynamics: an approach to reduce the isolation period of patients with COVID-19. J Med Virol. 2021;93(12):6794-6797. Available at : https://doi.org/10.1002/jmv.27206

13. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Recommended Daily Intakes of Calcium and Vitamin D. Washington (DC): National Academies Press (USA); 2011.

14. Tsun LY, Tafuni A, Affonso Fonseca FL, da Veiga GL, Macedo Gaiatto AC, de Godoy Moreira E Costa N, et al. Quantification of Vitamin D at Different Levels of Clinical Worsening of COVID-19. Curr Medicamento Metab. 2022;23(14):1124-1129. Available at: https://doi.org/10.2174/1389200224666230109162132

15. Szeto B, Zucker JE, LaSota ED, Rubin MR, Walker MD, Yin MT, et al. Vitamin D status and clinical outcomes of COVID-19 in hospitalized patients. Endocr Res. 2021;46(2):66-73. Available at: https://doi.org/10.1080/07435800.2020.1867162

16. Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240-4270. Available at: https://doi.org/10.3390/nu7064240

17. Jain A, Chaurasia R, Sengar NS, Singh M, Mahor S, Narain S. Analysis of vitamin D levels among asymptomatic and critically ill patients with COVID-19 and its correlation with inflammatory markers. Sci Rep. 2020;10(1):20191. Available at : https://doi.org/10.1038/s41598-020-77093-z

18. Rabaan AA, Tirupathi R, Sule AA, Aldali J, Mutair AA, Alhumaid S, et al. Viral dynamics and real-time RT-PCR Ct values correlate with disease severity in COVID-19. Diagnosis. 2021;11(6):1091. Available at: https://doi.org/10.3390/diagnostics11061091

19. Jassil NK, Sharma A, Bikle D, Wang X. Vitamin D-binding protein and 25-hydroxyvitamin D levels: emerging clinical applications. Endocr. Pract. 2017;23(5):605-613. Available at : https://doi.org/10.4158/EP161604.RA

Descargas

Publicado

2026-11-18

Número

Sección

Artigo Original

Cómo citar

1.
Carvalho VBL de, Azevedo MAF de, Primo MGS, Silva LAA da, Silva Filho JC da, Lima Neto AS, et al. Serum vitamin D concentration, viral load, and COVID-19 symptoms in outpatients. Medicina (Ribeirão Preto) [Internet]. 18 de noviembre de 2026 [citado 18 de noviembre de 2026];59(1):e-230013. Disponible en: https://revistas.usp.br/rmrp/article/view/230013